Skip to main content

Resultados relacionados

Resultados totales (Incluyendo duplicados): 8
Encontrada(s) 1 página(s)

Dipòsit Digital de la UB
Publication Artículo científico (JournalArticle)

CNS-border associated macrophages respond to acute ischemic stroke attracting granulocytes and promoting vascular leakage

  • Pedragosa Ollé, Jordi
  • Salas Perdomo, Angélica María
  • Gallizioli, Mattia
  • Cugota, Roger
  • Miró Mur, Francesc
  • Briansó, Ferran
  • Justicia Mercader, Carles
  • Pérez Asensio, Fernando
  • Márquez-Kisinousky, Leonardo
  • Urra, Xabier
  • Gieryng, Anna
  • Kaminska, Bozena
  • Chamorro Sánchez, Ángel
  • Planas Obradors, Anna Maria
The central nervous system (CNS) contains several types of immune cells located in specific anatomic compartments. Macrophages reside at the CNS borders surrounding the brain vessels, in leptomeningeal spaces and the choroid plexus, where they interact with the vasculature and play immunological surveillance and scavenging functions. We investigated the phenotypic changes and role of these macrophages in response to acute ischemic stroke. Given that CD163 expression is a hallmark of perivascular and meningeal macrophages in the rat and human brain, we isolated CD163+ brain macrophages by fluorescence activated cell sorting. We obtained CD163+ cells from control rats and 16 h following transient middle cerebral artery occlusion, after verifying that infiltration of CD163+ peripheral myeloid cells is negligible at this acute time point. Transcriptome analysis of the sorted CD163+ cells identified ischemia-induced upregulation of the hypoxia inducible factor-1 pathway and induction of genes encoding for extracellular matrix components and leukocyte chemoattractants, amongst others. Using a cell depletion strategy, we found that CNS border-associated macrophages participate in granulocyte recruitment, promote the expression of vascular endothelial growth factor (VEGF), increase the permeability of pial and cortical blood vessels, and contribute to neurological dysfunction in the acute phase of ischemia/reperfusion. We detected VEGF expression surrounding blood vessels and in some CD163+ perivascular macrophages in the brain tissue of ischemic stroke patients deceased one day after stroke onset. These findings show ischemia-induced reprogramming of the gene expression profile of CD163+ macrophages that has a rapid impact on leukocyte chemotaxis and blood-brain barrier integrity, and promotes neurological impairment in the acute phase of stroke.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Immunomodulatory role of IL-33 counteracts brain inflammation in stroke

  • Planas, Anna M.
Current research of the author is financed by the Spanish Ministry of Economy MINECO (SAF2014-56279), the European Community FP7 (grants n°278850, n°607962, and n°603043), and the Catalan Government (AGAUR, SGR-574), Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Antigen Presentation After Stroke

  • Miró-Mur, Francesc
  • Urra, Xabier
  • Gallizioli, Mattia
  • Chamorro, Ángel
  • Planas, Anna M.
Stroke induces a local inflammatory reaction and a plethora of innate immune responses in the brain where antigen-presenting cells become prominent. However, to date, it is still unclear whether antigen presentation is relevant to the neuropathological and functional outcome of stroke. Stroke does not trigger overt autoimmune reactions, but neural antigens have been found in lymphoid tissues of patient with stroke and it is unknown whether they promote tolerance or immune reactions that under certain conditions might contribute to the functional worsening observed in some patients. Autoantibodies to neural molecules have also been reported in patients with stroke, but the subclass of antibodies is important for their function, and the contribution of such findings to stroke outcome is not yet clear. Notably, stroke induces immunodepression highlighted by a transient lymphopenia, lymphoid organ atrophy, and monocyte deactivation. While these effects might reduce the chances of autoreactivity, they increase the risk of infection in patients with stroke and most frequently in those with severe stroke. Therefore any potential brain protective effect of stroke-induced immunodepression by attenuating or preventing lymphocyte-mediated brain damage is confounded by stroke severity and an increased incidence of infections. Systemic inflammation due to a number of comorbidities that are frequent in patients with stroke is also associated to a poor outcome. Herein, we review some relevant findings regarding the identification of neural antigens in stroke and discuss their potential contribution to the functional outcome of stroke., This work was supported by the Spanish Ministries of Economy MINECO (SAF2014-56279-R) and Health (FIS PI12/01437), and the European Community FP7 (FP7-PEOPLE-2013-ITN-n°07962, supporting M.G.). F.M.M. is supported by the “Red Invictus” of the Instituto de Salud Carlos III (RD12/0014/0011)., Peer Reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

CNS-border associated macrophages respond to acute ischemic stroke attracting granulocytes and promoting vascular leakage

  • Pedragosa, Jordi
  • Salas-Perdomo, Angélica
  • Gallizioli, Mattia
  • Cugota, Roger
  • Miró-Mur, Francesc
  • Briansó, Ferran
  • Justicia, Carles
  • Pérez-Asensio, Fernando J.
  • Márquez-Kisinousky, Leonardo
  • Urra, Xabier
  • Gieryng, Anna
  • Kaminska, Bozena
  • Chamorro, Ángel
  • Planas, Anna M.
The central nervous system (CNS) contains several types of immune cells located in specific anatomic compartments. Macrophages reside at the CNS borders surrounding the brain vessels, in leptomeningeal spaces and the choroid plexus, where they interact with the vasculature and play immunological surveillance and scavenging functions. We investigated the phenotypic changes and role of these macrophages in response to acute ischemic stroke. Given that CD163 expression is a hallmark of perivascular and meningeal macrophages in the rat and human brain, we isolated CD163+ brain macrophages by fluorescence activated cell sorting. We obtained CD163+ cells from control rats and 16 h following transient middle cerebral artery occlusion, after verifying that infiltration of CD163+ peripheral myeloid cells is negligible at this acute time point. Transcriptome analysis of the sorted CD163+ cells identified ischemia-induced upregulation of the hypoxia inducible factor-1 pathway and induction of genes encoding for extracellular matrix components and leukocyte chemoattractants, amongst others. Using a cell depletion strategy, we found that CNS border-associated macrophages participate in granulocyte recruitment, promote the expression of vascular endothelial growth factor (VEGF), increase the permeability of pial and cortical blood vessels, and contribute to neurological dysfunction in the acute phase of ischemia/reperfusion. We detected VEGF expression surrounding blood vessels and in some CD163+ perivascular macrophages in the brain tissue of ischemic stroke patients deceased one day after stroke onset. These findings show ischemia-induced reprogramming of the gene expression profile of CD163+ macrophages that has a rapid impact on leukocyte chemotaxis and blood-brain barrier integrity, and promotes neurological impairment in the acute phase of stroke., Supported by the Spanish Ministerio de Economia y Competitividad (SAF2014–56279-R and SAF2017–87459-R). JP and MG were supported by a PhD fellowship from the Catalan Research Agency (AGAUR) and the ITN program of the European Community (NeuroInflammation, FP7-PEOPLE-2013-ITN-n°607962), respectively. FMM is recipient of an ICT award by the Pla estratègic de recerca i innovació en salut (PERIS) of the Departament de Salut, Generalitat de Catalunya.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Antibodies against neural antigens in patients with acute stroke: joint results of three independent cohort studies

  • Royl, Georg
  • Fokou, Tsafack Judicael
  • Chunder, Rittika
  • Isa, Rakad
  • Münte, Thomas F.
  • Wandinger, Klaus-Peter
  • Schwaninger, Markus
  • Herrmann, Oliver
  • Valdueza, José Manuel
  • Brocke, Jan
  • Willkomm, Martin
  • Willemsen, Dietrich
  • Auffarth, Gerd U.
  • Mindorf, Swantje
  • Brix, Britta
  • Chamorro, Ángel
  • Planas, Anna M.
  • Urra, Xabier
Background and purpose: Ischemic stroke (IS) and hemorrhagic stroke (HemS) typically lead to a breakdown of the blood–brain barrier with neural antigen presentation. This presentation could potentially generate destructive auto-immune responses. Pre-existing antineuronal and antiglial antibodies (AA), predominantly NMDA receptor antibodies, have been reported in patients with stroke. This article summarizes three independent prospective studies, the Lübeck cohort (LC), Barcelona cohort (BC), and Heidelberg cohort (HC), exploring the frequency and clinical relevance of AA in patients with acute stroke (AS). Methods: In all cohorts together, 344 consecutive patients admitted with AS (322 × IS, 22 × HemS) were screened for AA in serum at admission. Clinical outcome parameters as well as a second AA screening were available at 30 days in the LC or at 90 days in the BC. A control group was included in the BC (20 subjects free from neurological disease) and the HC (78 neurological and ophthalmological patients without evidence for stroke). Results: The rate of positivity for AA was similar in control subjects and AS patients (13%, 95% CI [7%, 22%] vs. 13%, 95% CI [10%, 17%]; p = 0.46) with no significant difference between cohorts (LC 25/171, BC 12/75, HC 9/98). No patient had developed new AA after 30 days, whereas 2 out of 60 patients had developed new AA after 90 days. AA positive patients did not exhibit significant differences to AA negative patients in stroke subtype (LC, BC), initial stroke severity (BC, LC, HC), infarct volume (BC), and functional status at admission (BC, LC, HC) and follow-up (BC, LC). Conclusions: AS does not induce AA to a relevant degree. Pre-existing AA can be found in the serum of stroke patients, but they do not have a significant association with clinical features and outcomes., The research leading to these results received funding from the European Union’s Seventh Framework Program FP7 under Grant Agreement 607962 (nEUROinflammation) and from the ISCIII-Subdirección General de Evaluación (FIS PI15/00430, PI Prof. Ángel Chamorro) cofinanced by the Fondo Europeo de Desarrollo Regional (FEDER).
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Defining molecular identity and fates of CNS-border associated macrophages after ischemic stroke in rodents and humans

  • Rajan, Wenson D.
  • Wojtas, Bartosz
  • Gielniewski, Bartlomiej
  • Miró-Mur, Francesc
  • Pedragosa, Jordi
  • Zawadzka, Malgorzata
  • Pilanc, Paulina
  • Planas, Anna M.
  • Kaminska, Bozena
Central nervous system (CNS)-border associated macrophages (BAMs) maintain their steady-state population during adulthood and are not replaced by circulating monocytes under physiological conditions. Their roles in CNS integrity and functions under pathological conditions remain largely unknown. Until recently, BAMs and microglia could not be unequivocally distinguished due to expression of common macrophage markers. We investigated the transcriptional profiles of immunosorted BAMs from rat sham-operated and ischemic brains using RNA sequencing. We found that BAMs express the distinct transcriptional signature than microglia and infiltrating macrophages. The enrichment of functional groups associated with the cell cycle in CD163 cells isolated 3 days after the ischemic injury indicates the proliferative capacity of these cells. The increased number of CD163 cells 3 days post-ischemia was corroborated by flow cytometry and detecting the increased number of CD163 cells positive for a proliferation marker Ki67 at perivascular spaces. CD163 cells in the ischemic brains up-regulated many inflammatory genes and parenchymal CD163+ cells expressed iNOS, which indicates acquisition of a pro-inflammatory phenotype. In mice, BAMs typically express CD206 and we found a subset of these cells expressing CD169. Chimeric mice generated by transplanting bone marrow of donor Cx3cr1CCR2 mice to wild type hosts showed an increased number of CX3CR1CD169 perivascular macrophages 3 days post-ischemia. Furthermore, these cells accumulated in the brain parenchyma and we detected replacement of perivascular macrophages by peripheral monocytic cells in the sub-acute phase of stroke. In line with the animal results, post-mortem brain samples from human ischemic stroke cases showed time-dependent accumulation of CD163 cells in the ischemic parenchyma. Our findings indicate a unique transcriptional signature of BAMs, their local proliferation and migration of inflammatory BAMs to the brain parenchyma after stroke in animal models and humans., Studies were supported by the FP7-PEOPLE-2013-ITN grant n607962 (WDR) and CePT infrastructure fund from the European Union – the European Regional development Fund within the Operational Programme “Innovative Economy” for 2007–2013 and the Spanish Ministerio de Economia y Competitividad (MINECO, SAF2017-87459-R). We thank the Cytometry and Image Platforms of IDIBAPS and the Nencki institute for technical support. We are indebted to the Neurological Tissue Bank of the Biobank-Hospital Clinic-IDIBAPS for sample and data procurement, and to patient's relatives for giving consent to use the brain tissue. The use of CePT infrastructure financed by the European Union - The European Regional Development Fund within the Operational Programme "Innovative economy" for 2007-2013 is highly appreciated.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publication Artículo científico (JournalArticle)

Pharmacological Inhibition of Microglial Proliferation Supports Blood-Brain Barrier Integrity in Experimental Autoimmune Encephalomyelitis

  • Borjini, Nozha
  • Fernández, Mercedes
  • Giardino, Luciana
  • Sorokin, Lydia
  • Calzà, Laura
Blood-brain barrier dysfunction (BBB) is a primary characteristic of experimental autoimmune encephalomyelitis (EAE), an experimental model of multiple sclerosis (MS). We have previously shown that blocking microglial proliferation using GW2580, a selective inhibitor of CSF1R (Colony stimulating factor 1 receptor), reduced disease progression and severity and prevented the relapse phase. However, whether this was due to effects of GW2580 on the functional integrity of the BBB was not determined. Therefore, here, we examine BBB properties in rats during EAE under GW2580 treatment. Our data suggest that blocking early microglial proliferation through selective targeting of CSF1R signaling has a therapeutic effect in EAE by protecting BBB integrity and reducing peripheral immune cell infiltration. Taken together, our results identify a novel mechanism underlying the effects of GW2580, which could offer a novel therapy for MS., This work was supported by the European Union’s Seventh Framework Program FP7 under grant agreement 607962 (“nEUROinflammation”, Marie Curie Initial Training Networks (ITN), Call: FP7-PEOPLE-2013-ITN)., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publication Artículo científico (JournalArticle)

CNS-border associated macrophages respond to acute ischemic stroke attracting granulocytes and promoting vascular leakage

  • Pedragosa Ollé, Jordi
  • Salas Perdomo, Angélica María
  • Gallizioli, Mattia
  • Cugota, Roger
  • Miró Mur, Francesc
  • Briansó, Ferran
  • Justicia Mercader, Carles
  • Pérez Asensio, Fernando
  • Márquez-Kisinousky, Leonardo
  • Urra, Xabier
  • Gieryng, Anna
  • Kaminska, Bozena
  • Chamorro Sánchez, Ángel
  • Planas Obradors, Anna Maria
The central nervous system (CNS) contains several types of immune cells located in specific anatomic compartments. Macrophages reside at the CNS borders surrounding the brain vessels, in leptomeningeal spaces and the choroid plexus, where they interact with the vasculature and play immunological surveillance and scavenging functions. We investigated the phenotypic changes and role of these macrophages in response to acute ischemic stroke. Given that CD163 expression is a hallmark of perivascular and meningeal macrophages in the rat and human brain, we isolated CD163+ brain macrophages by fluorescence activated cell sorting. We obtained CD163+ cells from control rats and 16 h following transient middle cerebral artery occlusion, after verifying that infiltration of CD163+ peripheral myeloid cells is negligible at this acute time point. Transcriptome analysis of the sorted CD163+ cells identified ischemia-induced upregulation of the hypoxia inducible factor-1 pathway and induction of genes encoding for extracellular matrix components and leukocyte chemoattractants, amongst others. Using a cell depletion strategy, we found that CNS border-associated macrophages participate in granulocyte recruitment, promote the expression of vascular endothelial growth factor (VEGF), increase the permeability of pial and cortical blood vessels, and contribute to neurological dysfunction in the acute phase of ischemia/reperfusion. We detected VEGF expression surrounding blood vessels and in some CD163+ perivascular macrophages in the brain tissue of ischemic stroke patients deceased one day after stroke onset. These findings show ischemia-induced reprogramming of the gene expression profile of CD163+ macrophages that has a rapid impact on leukocyte chemotaxis and blood-brain barrier integrity, and promotes neurological impairment in the acute phase of stroke.